Changes in Beneficial Ownership · 4
CV Sciences, Inc.
CVSIOTCEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
primary_doc.xml
Filing details
- Report period
- 2026-07-16
- Issuer
- CV Sciences, Inc.
- Issuer CIK
- 0001510964
- Trading symbol
- CVSI
Reporting owner 1
- Name
- CHEEVER CHARLIE E III
- Reporting owner CIK
- 0001202557
- Relationship
- 10% owner
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | 2026-07-16 | P · Form 4 | 91,387 | A | 0.02 | 20,999,282 | D |
| Common Stock, $0.0001 par value per share | 2026-07-17 | P · Form 4 | 749,000 | A | 0.02 | 21,748,282 | D |
| Common Stock, $0.0001 par value per share | 2026-07-21 | P · Form 4 | 335,000 | A | 0.02 | 22,083,282 | D |
| Common Stock, $0.0001 par value per share | 2026-07-22 | P · Form 4 | 272,500 | A | 0.02 | 22,355,782 | D |
| Common Stock, $0.0001 par value per share | 2026-07-24 | P · Form 4 | 470,075 | A | 0.02 | 22,825,857 | D |
| Common Stock, $0.0001 par value per share | 2026-07-28 | P · Form 4 | 1,830,000 | A | 0.02 | 24,655,857 | D |
| Common Stock, $0.0001 par value per share | 2026-07-29 | P · Form 4 | 60,000 | A | 0.02 | 24,715,857 | D |
| Common Stock, $0.0001 par value per share | 2026-07-31 | P · Form 4 | 1,730,000 | A | 0.02 | 26,445,857 | D |
| Common Stock, $0.0001 par value per share | 2026-08-04 | P · Form 4 | 108,000 | A | 0.02 | 26,553,857 | D |
| Common Stock, $0.0001 par value per share | 2026-08-07 | P · Form 4 | 94,854 | A | 0.02 | 26,648,711 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Signature 1
- Signed
- Charles E. Cheever III
- Date
- 2026-09-09
Company context
CV Sciences, Inc. (OTCQB:CVSI) is a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products. The Company's products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling hemp-extract brand in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, +PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also produces non-cannabinoid supplements under its +PlusHLTH™ brand, with targeted formulations to optimize health, improve performance, and increase vitality. Our Cultured Foods™ brand provides a variety of 100% plant-based food products that are distributed primarily in the EU and other select markets. Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for